JP2021519599A5 - - Google Patents
Info
- Publication number
- JP2021519599A5 JP2021519599A5 JP2020554527A JP2020554527A JP2021519599A5 JP 2021519599 A5 JP2021519599 A5 JP 2021519599A5 JP 2020554527 A JP2020554527 A JP 2020554527A JP 2020554527 A JP2020554527 A JP 2020554527A JP 2021519599 A5 JP2021519599 A5 JP 2021519599A5
- Authority
- JP
- Japan
- Prior art keywords
- ospa
- antigenic
- polypeptide
- serotype
- antigenic ospa
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024002941A JP2024038345A (ja) | 2018-04-03 | 2024-01-12 | 抗原性ｏｓｐａポリペプチド |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862652210P | 2018-04-03 | 2018-04-03 | |
| US62/652,210 | 2018-04-03 | ||
| PCT/US2019/025367 WO2019195276A1 (en) | 2018-04-03 | 2019-04-02 | Antigenic ospa polypeptides |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024002941A Division JP2024038345A (ja) | 2018-04-03 | 2024-01-12 | 抗原性ｏｓｐａポリペプチド |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2021519599A JP2021519599A (ja) | 2021-08-12 |
| JP2021519599A5 true JP2021519599A5 (https=) | 2022-04-07 |
Family
ID=66397424
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020554527A Pending JP2021519599A (ja) | 2018-04-03 | 2019-04-02 | 抗原性ｏｓｐａポリペプチド |
| JP2024002941A Pending JP2024038345A (ja) | 2018-04-03 | 2024-01-12 | 抗原性ｏｓｐａポリペプチド |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024002941A Pending JP2024038345A (ja) | 2018-04-03 | 2024-01-12 | 抗原性ｏｓｐａポリペプチド |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US11993636B2 (https=) |
| EP (1) | EP3773697A1 (https=) |
| JP (2) | JP2021519599A (https=) |
| KR (1) | KR20210018205A (https=) |
| CN (1) | CN112584858A (https=) |
| CA (1) | CA3095174A1 (https=) |
| WO (1) | WO2019195276A1 (https=) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20210117359A (ko) * | 2016-11-07 | 2021-09-28 | 더 위스타 인스티튜트 오브 아나토미 앤드 바이올로지 | 라임병에 사용하기 위한 dna 항체 작제물 |
| EP3773698A1 (en) | 2018-04-03 | 2021-02-17 | Sanofi | Ferritin proteins |
| WO2019195314A2 (en) | 2018-04-03 | 2019-10-10 | Sanofi | Antigenic epstein barr virus polypeptides |
| JP7614841B2 (ja) | 2018-04-03 | 2025-01-16 | サノフイ | 抗原性呼吸器合胞体ウイルスポリペプチド |
| CN111217919B (zh) * | 2020-03-04 | 2020-12-01 | 中山大学 | 一种基于火球菌铁蛋白的新型冠状病毒s蛋白双区域亚单位纳米疫苗 |
| CN111217918B (zh) * | 2020-03-04 | 2020-11-10 | 中山大学 | 一种基于2,4-二氧四氢喋啶合酶的新型冠状病毒s蛋白双区域亚单位纳米疫苗 |
| WO2023044016A2 (en) * | 2021-09-17 | 2023-03-23 | Cspc Dophen Corporation | Antibody immune-stimulant conjugates and use thereof |
| JP2025500880A (ja) | 2021-12-17 | 2025-01-15 | サノフイ | ライム病ｒｎａワクチン |
| CA3256624A1 (en) | 2022-05-06 | 2023-11-09 | Sanofi | SIGNAL SEQUENCES FOR NUCLEIC ACID-BASED VACCINES |
| CN114736293B (zh) * | 2022-06-14 | 2022-09-02 | 中国农业科学院生物技术研究所 | SARS-CoV-2中和性纳米抗体、自组装铁蛋白融合纳米抗体及制备方法和应用 |
| WO2025015042A1 (en) * | 2023-07-10 | 2025-01-16 | Dynavax Technologies Corporation | Lyme disease vaccines comprising an adjuvant and a borrelia outer surface protein a antigen |
| WO2025015077A1 (en) * | 2023-07-10 | 2025-01-16 | Dynavax Technologies Corporation | Lyme disease vaccines comprising an adjuvant and borrelia outer surface protein a and c antigens |
Family Cites Families (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2057536C (en) * | 1990-12-21 | 1999-10-26 | John J. Dunn | Cloning and expression of borrelia lipoproteins |
| US6429199B1 (en) | 1994-07-15 | 2002-08-06 | University Of Iowa Research Foundation | Immunostimulatory nucleic acid molecules for activating dendritic cells |
| US6207646B1 (en) | 1994-07-15 | 2001-03-27 | University Of Iowa Research Foundation | Immunostimulatory nucleic acid molecules |
| US6239116B1 (en) | 1994-07-15 | 2001-05-29 | University Of Iowa Research Foundation | Immunostimulatory nucleic acid molecules |
| EP1167379A3 (en) | 1994-07-15 | 2004-09-08 | University Of Iowa Research Foundation | Immunomodulatory oligonucleotides |
| WO1998037919A1 (en) | 1997-02-28 | 1998-09-03 | University Of Iowa Research Foundation | USE OF NUCLEIC ACIDS CONTAINING UNMETHYLATED CpG DINUCLEOTIDE IN THE TREATMENT OF LPS-ASSOCIATED DISORDERS |
| US6406705B1 (en) | 1997-03-10 | 2002-06-18 | University Of Iowa Research Foundation | Use of nucleic acids containing unmethylated CpG dinucleotide as an adjuvant |
| EP1003531B1 (en) | 1997-05-20 | 2007-08-22 | Ottawa Health Research Institute | Processes for preparing nucleic acid constructs |
| AU760549B2 (en) | 1998-04-03 | 2003-05-15 | University Of Iowa Research Foundation, The | Methods and products for stimulating the immune system using immunotherapeutic oligonucleotides and cytokines |
| WO2001075436A1 (en) | 2000-04-03 | 2001-10-11 | Board Of Trustees Of The Leland Stanford Junior University | A method for protein structure alignment |
| ATE381575T1 (de) * | 2000-08-18 | 2008-01-15 | Univ New York State Res Found | Veränderte borrelia burgdorferi ospa |
| CN1659187A (zh) * | 2002-05-10 | 2005-08-24 | 新世纪药品有限公司 | 融合铁蛋白在疫苗和其他方面的应用 |
| US7774185B2 (en) | 2004-09-14 | 2010-08-10 | International Business Machines Corporation | Protein structure alignment using cellular automata |
| WO2009080719A1 (en) | 2007-12-21 | 2009-07-02 | Glaxosmithkline Biologicals S.A. | Vaccine |
| US20110117131A1 (en) * | 2008-04-09 | 2011-05-19 | Ning Huang | Production of OspA for Lyme Disease Control |
| CZ301541B6 (cs) * | 2008-06-25 | 2010-04-07 | Biologické centrum AV CR, v.v.i., Parazitologický ústav | Feritin 2 pro imunizaci organismu proti klíštatum |
| AU2011252844B2 (en) * | 2010-05-14 | 2014-07-03 | Baxalta GmbH | Chimeric OspA genes, proteins, and methods of use thereof |
| WO2012139069A2 (en) | 2011-04-07 | 2012-10-11 | Neotope Biosciences Limited | Compositions and methods for treating diseases of protein aggregation involving ic3b deposition |
| JP5795184B2 (ja) | 2011-04-22 | 2015-10-14 | 国立大学法人 奈良先端科学技術大学院大学 | 被検物質の電気化学的検出方法 |
| EP2515112B1 (en) | 2011-04-22 | 2015-08-12 | Sysmex Corporation | Method for electrochemically detecting analyte |
| BR112015001390B1 (pt) | 2012-07-26 | 2024-04-30 | The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc | Proteína de fusão, ácido nucleico isolado e uso de uma composição de vacina |
| CZ2014320A3 (cs) * | 2014-05-09 | 2015-11-18 | VÝZKUMNÝ ÚSTAV VETERINÁRNÍHO LÉKAŘSTVÍ, v.v.i. | Polyepitopový antigen, vakcinační konstrukt a vakcína pro prevenci lymeské boreliózy |
| US10363301B2 (en) * | 2014-05-27 | 2019-07-30 | The United States Of America As Represented By The Secretary, Department Of Health And Human Services | Stabilized influenza hemagglutinin stem region trimers and uses thereof |
| US9703095B2 (en) | 2015-01-05 | 2017-07-11 | Edward Pakhchyan | Light modulator for MEMS display |
| WO2016138160A1 (en) * | 2015-02-24 | 2016-09-01 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Middle east respiratory syndrome coronavirus immunogens, antibodies, and their use |
| EP3383426A1 (en) | 2015-12-04 | 2018-10-10 | Dana Farber Cancer Institute, Inc. | Vaccination with mica/b alpha 3 domain for the treatment of cancer |
| BR112018076015A8 (pt) | 2016-06-17 | 2022-06-28 | Sanofi Pasteur | Formulações imunogênicas compreendendo adjuvantes de polímero do ácido poliacrílico linear ou ramificado . |
| WO2018193063A2 (en) | 2017-04-19 | 2018-10-25 | Institute For Research In Biomedicine | Novel malaria vaccines and antibodies binding to plasmodium sporozoites |
| MA50813A (fr) | 2017-11-21 | 2020-09-30 | Modernatx Inc | Vaccins contre le virus d'epstein-barr |
-
2019
- 2019-04-02 KR KR1020207031415A patent/KR20210018205A/ko not_active Ceased
- 2019-04-02 EP EP19721893.6A patent/EP3773697A1/en active Pending
- 2019-04-02 WO PCT/US2019/025367 patent/WO2019195276A1/en not_active Ceased
- 2019-04-02 CN CN201980035045.3A patent/CN112584858A/zh active Pending
- 2019-04-02 CA CA3095174A patent/CA3095174A1/en active Pending
- 2019-04-02 JP JP2020554527A patent/JP2021519599A/ja active Pending
-
2020
- 2020-10-01 US US17/061,155 patent/US11993636B2/en active Active
-
2024
- 2024-01-12 JP JP2024002941A patent/JP2024038345A/ja active Pending
- 2024-04-19 US US18/640,574 patent/US20240417432A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021519599A5 (https=) | ||
| US20240067681A1 (en) | Subunit vaccine for treatment or prevention of a respiratory tract infection | |
| JP2010162023A5 (https=) | ||
| JP2023162283A5 (https=) | ||
| CN107847580B (zh) | 针对rsv的疫苗 | |
| JP2008529558A5 (https=) | ||
| JP2009544333A5 (https=) | ||
| JP2008530245A5 (https=) | ||
| JP2009520758A5 (https=) | ||
| JP2013507907A5 (https=) | ||
| JP2006512300A5 (https=) | ||
| JP2014507146A5 (https=) | ||
| JP2010500399A5 (https=) | ||
| CN1610697A (zh) | 戊型肝炎病毒单克隆抗体或其结合活性片段及其用途 | |
| JP2014503172A5 (https=) | ||
| HRP20170094T1 (hr) | Imunogeni pripravak | |
| JP2009515831A5 (https=) | ||
| JP2016514713A5 (https=) | ||
| JP2015509707A5 (https=) | ||
| JP2016504993A5 (https=) | ||
| JP2021506824A5 (https=) | ||
| JP2012516140A5 (https=) | ||
| JP2006506097A5 (https=) | ||
| JP2012506699A5 (https=) | ||
| RU2018116601A (ru) | Иммунногенный слитый белок |